董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Ara K. Hovnanian | 男 | Chairman of the Board, Chief Executive Officer, President and Director | 65 | 1247.82万美元 | 774.11 | 2023-12-18 |
| Edward A. Kangas | 男 | Director | 79 | 38.43万美元 | 35.44 | 2023-12-18 |
| Joseph A. Marengi | 男 | Director | 70 | 36.35万美元 | 18.50 | 2023-12-18 |
| J. Larry Sorsby | 男 | Director | 68 | 599.39万美元 | 93.65 | 2023-12-18 |
| Vincent Pagano Jr. | 男 | Director | 73 | 30.10万美元 | 16.51 | 2023-12-18 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Ara K. Hovnanian | 男 | Chairman of the Board, Chief Executive Officer, President and Director | 65 | 1247.82万美元 | 774.11 | 2023-12-18 |
| Brad G. O'Connor | 男 | Chief Financial Officer and Treasurer | 53 | 178.93万美元 | 20.02 | 2023-12-18 |
董事简历
中英对照 | 中文 | 英文- Ara K. Hovnanian
-
Ara K. Hovnanian自1997年7月以来一直担任首席执行官，此前，1988年他被任命为总裁，1983年被任命为执行副总裁。Hovnanian先生在1979年加入公司，自1981年起担任公司董事，从1998年至2009年11月担任副董事长。在2009年11月，公司创立者和前任主席同时也是Hovnanian先生的父亲 Kevork S. Hovnanian去世后，他被选为董事长。
Ara K. Hovnanian,has been Chief Executive Officer since July 1997 after being appointed President in 1988 and Executive Vice President in 1983. Mr. Hovnanian joined the Company in 1979 and has been a Director of the Company since 1981 and was Vice Chairman from 1998 through November 2009. In November 2009, he was elected Chairman of the Board following the death of Kevork S. Hovnanian, the chairman and founder of the Company and the father of Mr. Hovnanian. - Ara K. Hovnanian自1997年7月以来一直担任首席执行官，此前，1988年他被任命为总裁，1983年被任命为执行副总裁。Hovnanian先生在1979年加入公司，自1981年起担任公司董事，从1998年至2009年11月担任副董事长。在2009年11月，公司创立者和前任主席同时也是Hovnanian先生的父亲 Kevork S. Hovnanian去世后，他被选为董事长。
- Ara K. Hovnanian,has been Chief Executive Officer since July 1997 after being appointed President in 1988 and Executive Vice President in 1983. Mr. Hovnanian joined the Company in 1979 and has been a Director of the Company since 1981 and was Vice Chairman from 1998 through November 2009. In November 2009, he was elected Chairman of the Board following the death of Kevork S. Hovnanian, the chairman and founder of the Company and the father of Mr. Hovnanian.
- Edward A. Kangas
-
Edward A. Kangas，他一直担任Intuit公司董事（2007年以来）。他是薪酬和组织发展委员会主席，以及提名和治理委员会的成员。他一直担任Tenet Healthcare公司的非执行董事长（2003年以来）。从1989年到2000年，他曾担任Deloitte公司的全球主席和首席执行官。他担任德勤会计师事务所（Deloitte & Touche）（位于美国）的管理合伙人（从1989年到1994年）。他一直担任Hovnanian Enterprises公司（2002年以来）、United Technologies Corporation（2008年以来）、IntelSat公司（2012年以来）的董事会成员。他曾担任Electronic Data Systems Corporation（从2004年到2008年）、Eclipsys Corporation（从2004年到2010年）、Allscripts Healthcare Solutions（从2010年到2012年）的董事会成员。他持有the University of Kansas的学士学位，以及工商管理硕士学位。
Edward A. Kangas was the Global Chairman and Chief Executive Officer of Deloitte from December 1989 to May 2000 when he retired. He serves as the Chairman of the Board of Deutsche Bank USA Corporation and on the Board of IntelSat NYSE. He served as Lead Director at United Technologies from 2010 to 2018. He was on the Board of Directors of Tenet Healthcare Corporation (NYSE) from 2003 to 2019 Intuit from 2007 to 2016 AllScripts, Inc. (Nasdaq) from 2008 to 2012 and Virtus Inc. (Nasdaq) from 2018 to 2020. Mr. Kangas is a former Chairman of the Board of the National Multiple Sclerosis Society. Mr. Kangas was elected as a Director of Hovnanian Enterprises, Inc. in September 2002 is Independent Lead Director of the Company's Board of Directors, Chairman of the Company's Audit Committee and a member of the Company's Compensation Committee and Corporate Governance and Nominating Committee. - Edward A. Kangas，他一直担任Intuit公司董事（2007年以来）。他是薪酬和组织发展委员会主席，以及提名和治理委员会的成员。他一直担任Tenet Healthcare公司的非执行董事长（2003年以来）。从1989年到2000年，他曾担任Deloitte公司的全球主席和首席执行官。他担任德勤会计师事务所（Deloitte & Touche）（位于美国）的管理合伙人（从1989年到1994年）。他一直担任Hovnanian Enterprises公司（2002年以来）、United Technologies Corporation（2008年以来）、IntelSat公司（2012年以来）的董事会成员。他曾担任Electronic Data Systems Corporation（从2004年到2008年）、Eclipsys Corporation（从2004年到2010年）、Allscripts Healthcare Solutions（从2010年到2012年）的董事会成员。他持有the University of Kansas的学士学位，以及工商管理硕士学位。
- Edward A. Kangas was the Global Chairman and Chief Executive Officer of Deloitte from December 1989 to May 2000 when he retired. He serves as the Chairman of the Board of Deutsche Bank USA Corporation and on the Board of IntelSat NYSE. He served as Lead Director at United Technologies from 2010 to 2018. He was on the Board of Directors of Tenet Healthcare Corporation (NYSE) from 2003 to 2019 Intuit from 2007 to 2016 AllScripts, Inc. (Nasdaq) from 2008 to 2012 and Virtus Inc. (Nasdaq) from 2018 to 2020. Mr. Kangas is a former Chairman of the Board of the National Multiple Sclerosis Society. Mr. Kangas was elected as a Director of Hovnanian Enterprises, Inc. in September 2002 is Independent Lead Director of the Company's Board of Directors, Chairman of the Company's Audit Committee and a member of the Company's Compensation Committee and Corporate Governance and Nominating Committee.
- Joseph A. Marengi
-
Joseph A. Marengi从2007年7月至2012年3月是Austin Ventures的投资合伙人。在此之前，Marengi先生担任纳斯达克上市的戴尔（Dell）商业集团的高级副总裁。他主要负责戴尔单位的中型业务，服务美国的大型企业、政府、教育和医疗的客户。Marengi先生在1997年7月从 Novell Inc.转职入戴尔，在之前的企业，他担任总裁和首席运营官。他在1989年加入Novell，经过多次提拔以后他成为全球销售和业务部门的执行副总裁。Marengi先生从2008年至2013年还曾任 Quantum Corporation （NYSE）董事，从2008年至2012年任Entorian Technologies, Inc.的董事，公司前身是 the OTC Markets。Marengi先生在2006年3月被选为Hovnanian Enterprises, Inc.董事，现任公司薪酬委员会委员，公司治理和提名委员会委员。
Joseph A. Marengi, from July 2007 to March 2012 served as a Venture Partner for Austin Ventures. Prior to that, Mr. Marengi served as senior vice president for the Commercial Business Group of Dell Inc. Nasdaq. In this role, Mr. Marengi was responsible for the Dell units serving medium business, large corporate, government, education and healthcare customers in the United States. Mr. Marengi joined Dell in July 1997 from Novell Inc. (Nasdaq), where he was president and chief operating officer. Mr. Marengi also served on the Boards of Directors of Quantum Corporation (NYSE) from 2008 to 2013 and Entorian Technologies, Inc. (formerly, the OTC Markets) from 2008 to 2012. Mr. Marengi was elected to the Board of Directors of Hovnanian Enterprises, Inc. in March 2006 and is the Chairman of the Company's Compensation Committee and a member of the Company's Audit Committee and Corporate Governance and Nominating Committee. - Joseph A. Marengi从2007年7月至2012年3月是Austin Ventures的投资合伙人。在此之前，Marengi先生担任纳斯达克上市的戴尔（Dell）商业集团的高级副总裁。他主要负责戴尔单位的中型业务，服务美国的大型企业、政府、教育和医疗的客户。Marengi先生在1997年7月从 Novell Inc.转职入戴尔，在之前的企业，他担任总裁和首席运营官。他在1989年加入Novell，经过多次提拔以后他成为全球销售和业务部门的执行副总裁。Marengi先生从2008年至2013年还曾任 Quantum Corporation （NYSE）董事，从2008年至2012年任Entorian Technologies, Inc.的董事，公司前身是 the OTC Markets。Marengi先生在2006年3月被选为Hovnanian Enterprises, Inc.董事，现任公司薪酬委员会委员，公司治理和提名委员会委员。
- Joseph A. Marengi, from July 2007 to March 2012 served as a Venture Partner for Austin Ventures. Prior to that, Mr. Marengi served as senior vice president for the Commercial Business Group of Dell Inc. Nasdaq. In this role, Mr. Marengi was responsible for the Dell units serving medium business, large corporate, government, education and healthcare customers in the United States. Mr. Marengi joined Dell in July 1997 from Novell Inc. (Nasdaq), where he was president and chief operating officer. Mr. Marengi also served on the Boards of Directors of Quantum Corporation (NYSE) from 2008 to 2013 and Entorian Technologies, Inc. (formerly, the OTC Markets) from 2008 to 2012. Mr. Marengi was elected to the Board of Directors of Hovnanian Enterprises, Inc. in March 2006 and is the Chairman of the Company's Compensation Committee and a member of the Company's Audit Committee and Corporate Governance and Nominating Committee.
- J. Larry Sorsby
-
J. Larry Sorsby自1996年起一直担任Hovnanian Enterprises, Inc的首席财务官，自2000年11月起兼任执行副总裁。Sorsby先生从1981年3月到2000年11月担任过高级副总裁，在1997年被选为公司董事。他现任 The Children's Hospital of Philadelphia（CHOP）监事会主席，并在其机构改进委员会任职。
J. Larry Sorsby,has been Chief Financial Officer of Hovnanian Enterprises, Inc. since 1996, and Executive Vice President since November 2000. Mr. Sorsby was also Senior Vice President from March 1991 to November 2000 and was elected as a Director of the Company in 1997. He is Chairman of the Board of Visitors for Urology at The Children's Hospital of Philadelphia ("CHOP") and also serves on the Foundation Board of Overseers at CHOP. - J. Larry Sorsby自1996年起一直担任Hovnanian Enterprises, Inc的首席财务官，自2000年11月起兼任执行副总裁。Sorsby先生从1981年3月到2000年11月担任过高级副总裁，在1997年被选为公司董事。他现任 The Children's Hospital of Philadelphia（CHOP）监事会主席，并在其机构改进委员会任职。
- J. Larry Sorsby,has been Chief Financial Officer of Hovnanian Enterprises, Inc. since 1996, and Executive Vice President since November 2000. Mr. Sorsby was also Senior Vice President from March 1991 to November 2000 and was elected as a Director of the Company in 1997. He is Chairman of the Board of Visitors for Urology at The Children's Hospital of Philadelphia ("CHOP") and also serves on the Foundation Board of Overseers at CHOP.
- Vincent Pagano Jr.
-
Vincent Pagano Jr.直至2012年底退休曾是Simpson Thacher & Bartlett LLP合伙人，从1999年到2012年，他是公司资本市场业务的负责人，在此之前，从1996年到1999年是公司管理合作伙伴。在1996年至2012年期间，他在公司执行委员会任职。他目前还在Cheniere Energy Partners GP, LLC董事会任职，是 Cheniere Energy Partners NYSE MKT 和 L-3 Communications Holdings, Inc. （NYSE）的普通合伙人。Pagano先生在利哈伊大学（Lehigh University）工程咨询委员会任职。Pagano先生在2013年3月被选为Hovnanian Enterprises, Inc.董事，目前是公司提名委员会主席。
Vincent Pagano Jr. was a partner at the law firm of Simpson Thacher & Bartlett LLP until his retirement at the end of 2012. He was the head of the firm's capital markets practice from 1999 to 2012 and, before that, administrative partner of the firm from 1996 to 1999. He was a member of the firm's executive committee during nearly all of the 1996 - 2012 period. He serves on the Board of Directors of Cheniere Energy Partners GP, LLC, the general partner of Cheniere Energy Partners NYSE MKT, where he is chairman of the Conflicts Committee and a member of the Audit Committee, and also served on the Board of Directors of L3 Technologies, Inc. (NYSE) from 2013 until L3's merger with Harris Corporation in 2019 where he was chairman of the Nominating and Corporate Governance Committee and a member of the Audit Committee. Mr. Pagano was elected to the Board of Directors of Hovnanian Enterprises, Inc. in March 2013 is the Chairman of the Company's Corporate Governance and Nominating Committee and is a member of the Company's Audit Committee. - Vincent Pagano Jr.直至2012年底退休曾是Simpson Thacher & Bartlett LLP合伙人，从1999年到2012年，他是公司资本市场业务的负责人，在此之前，从1996年到1999年是公司管理合作伙伴。在1996年至2012年期间，他在公司执行委员会任职。他目前还在Cheniere Energy Partners GP, LLC董事会任职，是 Cheniere Energy Partners NYSE MKT 和 L-3 Communications Holdings, Inc. （NYSE）的普通合伙人。Pagano先生在利哈伊大学（Lehigh University）工程咨询委员会任职。Pagano先生在2013年3月被选为Hovnanian Enterprises, Inc.董事，目前是公司提名委员会主席。
- Vincent Pagano Jr. was a partner at the law firm of Simpson Thacher & Bartlett LLP until his retirement at the end of 2012. He was the head of the firm's capital markets practice from 1999 to 2012 and, before that, administrative partner of the firm from 1996 to 1999. He was a member of the firm's executive committee during nearly all of the 1996 - 2012 period. He serves on the Board of Directors of Cheniere Energy Partners GP, LLC, the general partner of Cheniere Energy Partners NYSE MKT, where he is chairman of the Conflicts Committee and a member of the Audit Committee, and also served on the Board of Directors of L3 Technologies, Inc. (NYSE) from 2013 until L3's merger with Harris Corporation in 2019 where he was chairman of the Nominating and Corporate Governance Committee and a member of the Audit Committee. Mr. Pagano was elected to the Board of Directors of Hovnanian Enterprises, Inc. in March 2013 is the Chairman of the Company's Corporate Governance and Nominating Committee and is a member of the Company's Audit Committee.
高管简历
中英对照 | 中文 | 英文- Ara K. Hovnanian
Ara K. Hovnanian自1997年7月以来一直担任首席执行官，此前，1988年他被任命为总裁，1983年被任命为执行副总裁。Hovnanian先生在1979年加入公司，自1981年起担任公司董事，从1998年至2009年11月担任副董事长。在2009年11月，公司创立者和前任主席同时也是Hovnanian先生的父亲 Kevork S. Hovnanian去世后，他被选为董事长。
Ara K. Hovnanian,has been Chief Executive Officer since July 1997 after being appointed President in 1988 and Executive Vice President in 1983. Mr. Hovnanian joined the Company in 1979 and has been a Director of the Company since 1981 and was Vice Chairman from 1998 through November 2009. In November 2009, he was elected Chairman of the Board following the death of Kevork S. Hovnanian, the chairman and founder of the Company and the father of Mr. Hovnanian.- Ara K. Hovnanian自1997年7月以来一直担任首席执行官，此前，1988年他被任命为总裁，1983年被任命为执行副总裁。Hovnanian先生在1979年加入公司，自1981年起担任公司董事，从1998年至2009年11月担任副董事长。在2009年11月，公司创立者和前任主席同时也是Hovnanian先生的父亲 Kevork S. Hovnanian去世后，他被选为董事长。
- Ara K. Hovnanian,has been Chief Executive Officer since July 1997 after being appointed President in 1988 and Executive Vice President in 1983. Mr. Hovnanian joined the Company in 1979 and has been a Director of the Company since 1981 and was Vice Chairman from 1998 through November 2009. In November 2009, he was elected Chairman of the Board following the death of Kevork S. Hovnanian, the chairman and founder of the Company and the father of Mr. Hovnanian.
- Brad G. O'Connor
Brad G. O'Connor 在2004年4月加入公司并开始担任副总裁和副企业主管。在2007年12月他被提拔为副总裁兼企业主管，随后在2011年5月他开始担任副总裁兼首席会计官。在加入公司之前，Connor先生曾任Amershem Biosciences企业主管，再之前，他是PricewaterhouseCoopers LLP审计部门的高级管理人员。
Brad G. O'Connor, Mr. O'Connor joined the Company in April 2004 as Vice President and Associate Corporate Controller. In December 2007 he was promoted to Vice President, Corporate Controller and then in May 2011 he also became Vice President, Chief Accounting Officer. Prior to joining the Company, Mr. O'Connor was the Corporate Controller for Amershem Biosciences, and prior to that a Senior Manager in the audit practice of PricewaterhouseCoopers LLP.- Brad G. O'Connor 在2004年4月加入公司并开始担任副总裁和副企业主管。在2007年12月他被提拔为副总裁兼企业主管，随后在2011年5月他开始担任副总裁兼首席会计官。在加入公司之前，Connor先生曾任Amershem Biosciences企业主管，再之前，他是PricewaterhouseCoopers LLP审计部门的高级管理人员。
- Brad G. O'Connor, Mr. O'Connor joined the Company in April 2004 as Vice President and Associate Corporate Controller. In December 2007 he was promoted to Vice President, Corporate Controller and then in May 2011 he also became Vice President, Chief Accounting Officer. Prior to joining the Company, Mr. O'Connor was the Corporate Controller for Amershem Biosciences, and prior to that a Senior Manager in the audit practice of PricewaterhouseCoopers LLP.